Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$22.20 USD
-0.67 (-2.93%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $22.20 0.00 (0.00%) 6:00 PM ET
2-Buy of 5 2
D Value F Growth B Momentum D VGM
Brokerage Reports
Edgewise Therapeutics, Inc. [EWTX]
Reports for Purchase
Showing records 41 - 60 ( 73 total )
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Breaking The Mold But Not The Fast Fibers - Continue to Like the EWTX Strategy
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road: Bullish on Becker, DMD EDG-5506 Opportunities
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Motoring Forward: EDG-5506 Efficacy, Safety Profile Remains Intact At 6 Months
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Walking on Sunshine - Latest ARCH Update Shows NSAA Improvements
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Moving Right Along - Follow-Up Thoughts on EDG-5506 Four Month Update
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Runnin'' Down A Dream - Phase 2 ARCH Data Shows Continued EDG-5506 Progress
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ARCH You Glad We Have Data Coming? All Efforts on Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Not Skipping a Beat - BMD, Cardiac Efforts Moving On Track
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Fast Turnaround - EDG-5506 Initial Data Generate Meaningful Biomarker Changes
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Walk Like A Duck... Quack Like A Duck... EDG-5506 Moving In Right Direction
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L